Company: INVUP
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001193
Chunk: 1079

Company: Investview, Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 1
Chunk 1079
---
 directors of the Company and surrendered 150,000,000 shares of our common
stock. Subsequently, on September 9, 2023, we closed on the purchase in a private transaction of an aggregate of 302,919,223 shares of
the Company’s common stock from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related
entities. These shares were purchased for aggregate consideration of $2,922,380, representing a price of $0.00964739 per share, with
one-eighth of the purchase price paid on or about the closing, with the balance payable in a series of equal quarterly payments over
seven (7) consecutive quarters thereafter.

During
September 2021, we acquired, among other assets, a proprietary algorithmic trading platform from MPower, a business controlled by two
members of our Board of Directors. The assets of MPower were acquired in consideration of the issuance of Class B Redeemable Units consisting
of non-voting membership interests in our wholly owned subsidiary IFGH that are in the future redeemable for 565,000,000 Company common
shares, presently representing over 23% of the Company’s current fully-diluted shares. To date, we have been unable to monetize
on the assets we purchased from MPower.

Further,
by virtue of an April 27, 2020 convertible note financing arrangement we have with DBR Capital, LLC (“DBR Capital”) (see
“ITEM 13. Certain Relationships and Related Transactions, and Director Independence”), an affiliate of our Chairman, David
B. Rothrock, we borrowed the principal amount of $3,300,000 under an aggregate of three convertible promissory notes that bear rates
of interest between 20.00% and 38.50% per annum and are subject to conversion by DBR Capital at a price of $0.007 per share. Under the
first three loans, DBR Capital had the right to lend to the Company up to an additional $7.7 million for which the Company had no call
rights, on substantially the same terms as the prior loans, through December 31, 2024. In February 2025, the terms of the note financing
arrangement were amended so that DBR Capital has been given until August 31, 2025 to lend to the Company a minimum of $2,000,000, and
until December 31, 2026